Alzheimer’s Genetics Update: A new Japanese reappraisal of APOE-e4 homozygotes suggests Alzheimer’s risk is about 12–15 times higher, lower than decades-old estimates, reshaping how genetic risk is discussed. AI for Early Disease Detection: A study describes an AI eye-photo system that can flag risk for diabetes, blood pressure, cholesterol, gout, osteoporosis and thyroid disease in about 31 seconds—potentially turning routine eye exams into broader health screening. Drug Access & Trial Progress: AriBio says dosing is complete in its global Phase 3 POLARIS-AD trial of AR1001 for early Alzheimer’s, with topline results expected later in 2026. Cancer Care in China: Innovent and Lilly expand commercialization in mainland China for Verzenios (abemaciclib) via a distribution and promotion agreement. Public Health Policy on Alcohol: A WHO-linked symposium reiterates alcohol is a Group 1 carcinogen and stresses total consumption control—taxes, supply restrictions and education—as the most effective approach. Food Safety/Consumer Risk: EU anti-fraud officials report a crackdown on unsafe, misdeclared vapes flooding Europe, with many seized products failing health and safety rules. Wellness & Lifestyle: Trip.com data shows Chinese summer travel is shifting toward “experience” trips—camping, rafting, nightlife and forest wellness—rather than pure sightseeing.